Rita Jain serves as Executive at Akebia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rita Jain has executed 17 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 5, 2026 involved receiving (via award) 240,000 shares valued at $0.
Rita Jain currently holds 240,000 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rita Jain has been a net neutral trader of AKBA stock. They have purchased $0 and sold $0 worth of shares.
Rita Jain's most recent insider trade was on Jan 5, 2026, when they sold 240,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 20, 2022 | CCXI | $0 | Disposition | 35,863 | $N/A | Discretionary |
| May 20, 2022 | CCXI | $0 | Option Exercise | 7,726 | $N/A | Discretionary |
| Mar 27, 2022 | CCXI | $0 | Option Exercise | 5,251 | $N/A | Discretionary |
| May 21, 2021 | CCXI | $0 | Option Exercise | 4,660 | $N/A | Discretionary |
| Mar 27, 2021 | CCXI | $0 | Option Exercise | 5,251 | $N/A | Discretionary |
| Mar 19, 2021 | IMVT | $0 | Award | 109,365 | $N/A | Discretionary |
| Mar 19, 2021 | IMVT | $0 | Award | 97,600 | $N/A | Discretionary |
| Mar 19, 2021 | IMVT | $0 | Award | 11,765 | $N/A | Discretionary |
| Jan 22, 2021 | IMVT | $0 | Award | 20,000 | $N/A | Discretionary |
| Mar 27, 2020 | CCXI | $0 | Option Exercise | 5,251 | $N/A | Discretionary |
| May 23, 2019 | CCXI | $0 | Award | 7,724 | $N/A | Discretionary |
| Apr 11, 2019 | AKBA | $33.9K | Disposition | 4,409 | $7.70 | Discretionary |
| Feb 28, 2019 | AKBA | $0 | Award | 80,000 | $N/A | Discretionary |
| Dec 12, 2018 | AKBA | $77.4K | Payment | 8,659 | $8.94 | Discretionary |
| Feb 28, 2018 | AKBA | $0 | Award | 29,400 | $N/A | Discretionary |